Latest News

X is reportedly back online for some people in Brazil

X is reportedly back online for some people in Brazil

X is reportedly back online for many people in Brazil, more than two weeks after the service was blocked in the country. The change, though, isn’t because Brazil’s government has reversed its stance on the Elon Musk-owned platform. Instead, it seems that X has begun using Cloudflare’s DNS service, which is for now helping the social network avoid the Brazilian…
Read More
Google wins appeal against $1.7 billion EU fine for ‘abusive’ advertising practices

Google wins appeal against $1.7 billion EU fine for ‘abusive’ advertising practices

The amount of fines Google has to pay in Europe may have become just a bit smaller. It has successfully convinced the European Union's General Court to annul the €1.5 billion ($1.7 billion) penalty levied against it back in 2019 for what the European Commission described as "abusive practices in online advertising." According to the Financial Times, the General Court…
Read More
Report: Google offered to sell AdX to end EU antitrust suit

Report: Google offered to sell AdX to end EU antitrust suit

In an effort to quell monopoly concerns in the EU, Google reportedly offered to sell its AdX advertising marketplace. Sources told Reuters that European publishers rejected Google's offer, arguing that the company would have to divest more in order to dismantle the conflicts of interest in its online advertising operations. Lawyers familiar with the antitrust cases said this was the…
Read More
Neuralink says the FDA designated its Blindsight implant as a ‘breakthrough device’

Neuralink says the FDA designated its Blindsight implant as a ‘breakthrough device’

Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a "breakthrough device." The company is developing the technology in an attempt to restore blind people's sight.Manufacturers who apply to the FDA's voluntary breakthrough devices program and receive the designation from the agency are granted "an opportunity to interact with FDA experts through several different program…
Read More